Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens

Which stock wins in a battle between these pharmacy giants?

Better Buy: Walgreens Boots Alliance vs. CVS Health

The drug store chain just hired an executive from Fitbit as it tries to expand beyond pharmacies and consumer product sales.

Does CVS Health Have Aspirations To Be a Tech Company?

AmerisourceBergen

AECOM

Anixter

Best Buy

Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.

5 Stocks in the Limelight After Recent Broker Rating Upgrade

AbbVie

Alexion Pharma

Bausch Health Companies Inc

Cigna

Intercept Pharma

Johnson & Johnson

Eli Lilly

Pfizer

PRA Health Sciences

Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.

10 Healthcare Stocks to Buy Despite the Headlines

CVS has hired Fitbit executive Adam Pellegrini to lead its consumer health efforts, according to an internal memo obtained by CNBC.

CVS hires Fitbit executive to lead consumer health

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

CVS Health (CVS) Up 6.3% Since Last Earnings Report: Can It Continue?

Walgreens Boots Alliance Inc , CVS Health Corp  and supermarket chain Wegmans Food Markets Inc said on Thursday they would start asking customers to not openly carry firearms in their stores, joining Walmart Inc  and Kroger Co , in a change of gun policy following several deadly mass shootings in the United States.

Walgreens, CVS, Wegmans ask shoppers to not openly carry firearms

Drugstore chains Walgreens Boots Alliance and CVS Health on Thursday joined Walmart and Kroger in asking shoppers not to openly carry guns in their stores.

Walgreens, CVS join Walmart, Kroger in asking shoppers not to openly carry guns in stores

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp to merge with health insurer Aetna said on Wednesday that the agreement was in fact legal under antitrust law.

US judge approves CVS purchase of insurer Aetna

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp  to merge with insurer Aetna said on Wednesday that the agreement was legal under antitrust law.

U.S. judge approves CVS purchase of insurer Aetna

ACADIA Pharma

Procter & Gamble

Top Ranked Momentum Stocks to Buy for August 29th

Asbury Automotive Group

Cincinnati Bell

Since brokers follow stocks in their coverage minutely, their advice is invaluable for individual investors as the latter aim for lucrative returns.

Recent Broker Rating Upgrades Add Luster to These 5 Stocks

Avista

Broadcom

Bristol-Myers

Gap Inc

International Game Technology

Kellogg

SL Green Realty

State Street

These 10 stocks don't quite qualify as "set it and forget it" plays. All have some degree of risk.

10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond

CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.

CVS Health Banks on Health Care Benefit Prospects Amid Woes

AutoNation

Clearwater Paper

Diebold Nixdorf Inc

Investors aim to generate maximum returns from their portfolio. Therefore, it is in their best interests to pay heed to well-researched information accumulated by brokers.

5 Stocks That Brokers Currently Love

Gilead Sciences

3 Embarrassingly Cheap Dividend Stocks.

Despite rapidly changing dynamics in the pharmaceutical industry, CVS Health looks like the clear leader.

3 Rock-Solid Reasons Why CVS Health Is the Best Pharmacy Stock on the Market

Flexion Therapeutics

Guardant Health Inc

For a few companies, the second half of 2019 will probably work out better than investors dared hope for earlier this year.

3 Healthcare Stocks With Rising Expectations

Carvana

InnerWorkings

Jacobs Engineering Group

MercadoLibre

Roku

TransDigm

Tyson Foods

Take-Two Interactive Software

Zoetis

Earnings season may be winding down, but there are many companies still reporting earnings.

10 Serious Earnings Season Winners from the Week of August 10

UnitedHealth Group

CVS Health demolished Wall Street expectations with its latest quarterly report, and those expectations must now be reset.
The post Start Comparing CVS Stock to UnitedHealth appeared first on InvestorPlace.

Start Comparing CVS Stock to UnitedHealth

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy CVS Health (CVS) Stock?

CVS (CVS) reported its Q2 earnings results Wednesday morning and beat our estimates by 11%.

CVS Stock Jumps 7% After Strong Earnings: What's Next for the Pharmacy Giant?

Shares of CVS Health Corp. (NYSE:CVS) soared 7.45% to $58.12 at close on Wednesday after announcing second-quarter results before the opening bell.

CVS Health Corp Is Back to Profit

Disney

Bank of America

Options trading was buzzing in CVS Health, Disney and Bank of America Thursday. Here are the metrics that matter moving forward.

Thursday’s Vital Data: CVS Health, Disney and Bank of America

News for CVS Health Stock (CVS)